Basiliximab in Moderate to Severe Ulcerative Colitis

Clinical trial NCT00430898 · COMPLETED

Trial details

NCT number: NCT00430898
Sponsor: Cerimon Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2007-01-01
Primary completion: 2008-09-01
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.